Simavita Limited: Resignation of Company Secretary

SYDNEY, AUSTRALIA--(Marketwired - Dec. 22, 2015) - Simavita Limited ("Simavita" or the "Company") (TSX VENTURE:SV)(ASX:SVA), a global leader in the digital healthcare sector, announces the resignation of its Company Secretary and Chief Financial Officer, Tom Howitt, effective Friday, January 15, 2016.

The search for a replacement for Mr. Howitt has commenced, and in the interim, Ms. Peta Jurd, the Company's Chief Commercial Officer, will oversee the finance and accounting functions of the Company. Ms. Jurd is a qualified accountant and has previous experience as the CFO and Company Secretary of Australia's largest (at the time) private hospital group. Ms. Jurd also has Chartered Secretary and Legal qualifications.

Mr. Howitt's Company Secretary role will be replaced by the dual appointment of a professional Company Secretarial services firm, and the appointment of Ms. Jurd as joint Company Secretary.

"On behalf of the Board, I'd like to thank Tom for his service to Simavita," said CEO, Philippa Lewis. "Tom joined the Company in December 2013 and has brought valuable experience to the role. We wish him all the best in his future endeavours."

For further information, see our website (www.simavita.com) or contact the persons outlined below.

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrumented incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events and related nursing interventions during a compulsory or recommended assessment period in residential aged care facilities; and to then develop evidence-based person-centred incontinence care plans.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

The TSX Venture Exchange ("TSX-V") has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this Release.

Except for historical information, this announcement may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, the anticipated date of on the ASX, changing market conditions, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.